Cacace Angela M 4
4 · ARVINAS, INC. · Filed Feb 25, 2026
Insider Transaction Report
Form 4
ARVINAS, INC.ARVN
Cacace Angela M
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1]2026-02-23$12.16/sh−1,038$12,622→ 150,194 total - Sale
Common Stock
[F2]2026-02-23$12.16/sh−2,571$31,263→ 147,623 total
Footnotes (2)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-quarter of the reporting person's restricted stock units (RSUs) granted on February 22, 2023. The sale does not represent a discretionary trade.
- [F2]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on February 23, 2024. The sale does not represent a discretionary trade.
Signature
/s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace|2026-02-25